4‐Amino‐2,4‐pentadienoate‐containing cyclolipodepsipeptides (APD‐CLDs) represent a structurally distinctive family of natural products known for their selective activity against hypoxic cancer cells. To explore the structural diversity of APD‐CLDs, we have identified and prioritized cryptic APD‐CLD biosynthetic gene clusters (BGCs) for compound discovery. Using a combination of genetic and chemical methods, we successfully activated three dormant BGCs, leading to the discovery of 12 new APD‐CLDs. These newly discovered metabolites significantly expanded the diversity of the APD‐CLD family, with chloromalamides and arabimalamides representing the first halogenated and glycosylated members, respectively. Unexpectedly, chloromalamides and arabimalamides exhibited potent antiplasmodial activity, with IC 50 values in the 25–161 nM range against drug‐sensitive and multidrug‐resistant Plasmodium falciparum strains. Phenotypic studies revealed arabimalamide B halted parasite development during the asexual blood stage life cycle, resulting in enlarged digestive vacuoles, dispersed hemozoin, and ultimately reduced reinvasion efficiency. These phenotypes are reminiscent of the effect of chloroquine and other 4‐aminoquinoline drugs, suggesting that arabimalamides may disrupt the parasite's heme detoxification mechanism. Biosynthetic studies identified key scaffold‐forming and modifying enzymes, including a rare membrane glycosyltransferase in arabimalamide biosynthesis. Together, these findings unveil APD‐CLDs as new antimalarial lead scaffolds and set the stage for structural diversification and optimization.
Southeast Asia (SEA) harbors one of the world’s richest reservoirs of marine biodiversity, offering immense potential for natural product discovery. This review presents a comprehensive survey of sponge-derived marine natural products (MNPs), with notable activity, reported from SEA over the past two decades, highlighting their chemical diversity, biological activities and regional research trends. Analysis of the past two decades of MNPs data reveals that sponges (Phylum Porifera) remain the dominant source of new MNPs, representing nearly half of all discoveries in the region. Indonesia, Vietnam, and Thailand are leading contributors, with Indonesia exhibiting the highest productivity but limited local research leadership. The South China Sea and Indonesian archipelagos emerge as biodiversity and bioprospecting hotspots, yet large areas remain underexplored. Bioactive metabolites isolated from SEA sponges demonstrate potent anticancer, antimicrobial, anti-inflammatory, antiviral and enzyme-inhibitory properties, underscoring their value for pharmaceutical innovation. Despite this promise, uneven research capacity, infrastructure gaps and environmental degradation constrain sustainable exploitation. By consolidating recent advances in lead compound development and identifying key taxonomic as well as geographic priorities, this review strengthens the scientific foundation for marine drug discovery in SEA and supports integration of bioprospecting with regional Blue Economy and biodiversity conservation agendas and programs.
A general copper(I) chloride (CuCl) catalyst system was developed for the N-arylation of benzotriazoles using substituted aryl iodides under ligand-free conditions. Herein, 20 mol% CuCl was used to synthesise N-aryl benzotriazole derivatives in moderate to good yields. The practicality and low cost of this method make it well suited for both academic research and large-scale industrial applications.